Cell-mediated immunity induced by chimeric tetravalent dengue vaccine in naive or flavivirus-primed subjects
- 30 August 2008
- journal article
- Published by Elsevier BV in Vaccine
- Vol. 26 (45), 5712-5721
- https://doi.org/10.1016/j.vaccine.2008.08.019
Abstract
No abstract availableKeywords
This publication has 25 references indexed in Scilit:
- Cross‐Reactive Memory CD8+T Cells Alter the Immune Response to Heterologous Secondary Dengue Virus Infections in Mice in a Sequence‐Specific MannerThe Journal of Infectious Diseases, 2008
- DengueThe Lancet, 2007
- Increased frequencies of CD4+CD25high regulatory T cells in acute dengue infectionThe Journal of Experimental Medicine, 2007
- Immunopathological mechanisms in dengue and dengue hemorrhagic feverCurrent Opinion in Infectious Diseases, 2006
- Live Attenuated Chimeric Yellow Fever Dengue Type 2 (ChimeriVax™-DEN2) Vaccine: Phase I Clinical Trial for Safety and Immunogenicity: Effect of Yellow Fever Pre-immunity in Induction of Cross Neutralizing Antibody Responses to AllHuman Vaccines, 2006
- Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic feverNature Medicine, 2003
- Cytokine cascade in dengue hemorrhagic fever: implications for pathogenesisFEMS Immunology & Medical Microbiology, 2000
- Phototyping: comprehensive DNA typing for HLA‐A, B, C, DRB1, DRB3, DRB4, DRB5 & DQB1 by PCR with 144 primer mixes utilizing sequence‐specific primers (PCR‐SSP)Tissue Antigens, 1995
- Human T cell responses to dengue virus antigens. Proliferative responses and interferon gamma production.JCI Insight, 1989
- Antibody-enhanced dengue virus infection in primate leukocytesNature, 1977